Epidemiology of fragile X syndrome: a systematic review and meta-analysis
- PMID: 24700618
- DOI: 10.1002/ajmg.a.36511
Epidemiology of fragile X syndrome: a systematic review and meta-analysis
Abstract
Prevalence estimates for fragile X syndrome vary considerably. This systematic review and meta-analysis was conducted to provide an accurate prevalence estimate for this disorder using primary publications in PubMed, Embase, and the Cochrane library. Data were pooled using Bayesian fixed-effects and random-effects models. Primary analyses assessed the frequency of the full mutation and premutation in males and females in the total population (no bias against individuals with intellectual disability) and in female carriers of the premutation in normal populations (biased against individuals with intellectual disability), based on diagnosis by polymerase chain reaction or Southern blotting. A sensitivity analysis included studies using any diagnostic testing method and conference abstracts. Sixty-eight recorded observations provided data for the primary (56 observations) and sensitivity (12 observations) analysis. Using the random-effects model, frequency of the full mutation was 1.4 (95% CI: 0.1-3.1) per 10,000 males and 0.9 (95% CI: 0.0-2.9) per 10,000 females (1:7,143 and 1:11,111, respectively) in the total population. The premutation frequency was 11.7 (95% CI: 6.0-18.7) per 10,000 males and 34.4 (95% CI: 6.3-83.3) per 10,000 for females (1:855 and 1:291, respectively) in the total population. The prevalence of female carriers of the premutation in the normal population was 34.4 (95% CI: 8.9-60.3) per 10,000, or 1:291. Sensitivity analyses resulted in similar prevalence estimates but with wider heterogeneity. Prevalence estimates for the full mutation from this meta-analysis are lower than those in previous reviews of fragile X syndrome epidemiological data.
Keywords: epidemiology; fragile X syndrome; full mutation; premutation.
© 2014 Wiley Periodicals, Inc.
Similar articles
-
An assessment of screening strategies for fragile X syndrome in the UK.Health Technol Assess. 2001;5(7):1-95. doi: 10.3310/hta5070. Health Technol Assess. 2001. PMID: 11262423 Review.
-
Fragile X analysis of 1112 prenatal samples from 1991 to 2010.Prenat Diagn. 2011 Oct;31(10):925-31. doi: 10.1002/pd.2815. Epub 2011 Jun 30. Prenat Diagn. 2011. PMID: 21717484
-
Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.Hong Kong Med J. 2017 Apr;23(2):110-6. doi: 10.12809/hkmj164936. Epub 2017 Mar 3. Hong Kong Med J. 2017. PMID: 28253484
-
Fragile X Premutation Carrier Epidemiology and Symptomatology in Israel-Results from a Tertiary Child Developmental Center.Cerebellum. 2016 Oct;15(5):595-8. doi: 10.1007/s12311-016-0804-y. Cerebellum. 2016. PMID: 27312842
-
Health problems in females carriers of premutation in the FMR1 gene.Psychiatr Pol. 2017 Oct 29;51(5):899-907. doi: 10.12740/PP/65778. Epub 2017 Oct 29. Psychiatr Pol. 2017. PMID: 29289969 Review. English, Polish.
Cited by
-
Are We Ready for Fragile X Newborn Screening Testing?-Lessons Learnt from a Feasibility Study.Int J Neonatal Screen. 2018 Feb 13;4(1):9. doi: 10.3390/ijns4010009. eCollection 2018 Mar. Int J Neonatal Screen. 2018. PMID: 33072935 Free PMC article.
-
Diagnostic Process for Autism Spectrum Disorder: A Meta-Analysis of Worldwide Clinical Practice Guidelines for the Initial Somatic Assessment.Children (Basel). 2022 Dec 1;9(12):1886. doi: 10.3390/children9121886. Children (Basel). 2022. PMID: 36553329 Free PMC article. Review.
-
Multifaceted Changes in Synaptic Composition and Astrocytic Involvement in a Mouse Model of Fragile X Syndrome.Sci Rep. 2019 Sep 25;9(1):13855. doi: 10.1038/s41598-019-50240-x. Sci Rep. 2019. PMID: 31554841 Free PMC article.
-
Automatic vocalisation-based detection of fragile X syndrome and Rett syndrome.Sci Rep. 2022 Aug 3;12(1):13345. doi: 10.1038/s41598-022-17203-1. Sci Rep. 2022. PMID: 35922535 Free PMC article.
-
Connective Tissue Disorders and Fragile X Molecular Status in Females: A Case Series and Review.Int J Mol Sci. 2022 Aug 13;23(16):9090. doi: 10.3390/ijms23169090. Int J Mol Sci. 2022. PMID: 36012355 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical